［1］Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans［J］. Clin Microbiol Rev, 1995, 8(4): 515-548.
［4］Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Read I. Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients［J］.J Clin Microbiol, 2009, 47(1): 129-133.
［6］Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F, et al. Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan［J］. J Clin Microbiol, 2005, 43(6): 2929-2931.
［7］Sivertsen EA, Torfoss D. Cryptococcal meningitis［J］. Tidsskr Nor Laegeforen, 2004, 124(1): 28-30.
［8］Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America［J］.Clin Inefect Dis, 2010, 50(3): 291-322.
［10］van der Horst CM, Saag MS, Clood GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome［J］. N Engl J Med, 1997, 337(1): 15-21.
